β-内酰胺酶抑制剂与不动杆菌属 - Suppr | 超能文献

Beta-lactamase inhibitors and Acinetobacter spp.

作者信息

Eng R H, Smith S M, Cherubin C E

出版信息

J Antimicrob Chemother. 1990 Sep;26(3):449-51. doi: 10.1093/jac/26.3.449.

DOI:10.1093/jac/26.3.449

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Beta-lactamase inhibitors and Acinetobacter spp.β-内酰胺酶抑制剂与不动杆菌属

J Antimicrob Chemother. 1990 Sep;26(3):449-51. doi: 10.1093/jac/26.3.449.

2

Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.阿莫西林-克拉维酸、氨苄西林-舒巴坦和哌拉西林-他唑巴坦对携带已知β-内酰胺酶的大肠杆菌和奇异变形杆菌菌株的体外比较活性。

Infection. 1991 Mar-Apr;19(2):106-9. doi: 10.1007/BF01645578.

3

[The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].[所谓的增效青霉素（阿莫西林克拉维酸钾和他唑巴坦）的体外有效性]

Cas Lek Cesk. 1995 Sep 6;134(17):558-61.

4

Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.使用β-内酰胺/β-内酰胺酶抑制剂组合作为抗分枝杆菌药物。

Microbios. 1993;76(309):251-61.

5

Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.牛乳铁蛋白对氨苄西林/舒巴坦（优立新）、阿莫西林/克拉维酸（奥格门汀）、替卡西林克拉维酸（特泯菌）和哌拉西林-他唑巴坦（特治星）针对运动性气单胞菌临床分离株和环境分离株的最低抑菌浓度的影响。

J Am Osteopath Assoc. 2005 Jan;105(1):25-6.

6

Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).哌拉西林与β-内酰胺酶抑制剂他唑巴坦（YTR 830）联合应用的体外比较活性

Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):481-8. doi: 10.1016/0732-8893(89)90082-5.

7

In vitro activity of YTR 830.YTR 830的体外活性。

J Chemother. 1989 Jun;1(3):151-4. doi: 10.1080/1120009x.1989.11738883.

8

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.哌拉西林与β-内酰胺酶抑制剂他唑巴坦、克拉维酸和舒巴坦联合使用的体外和体内比较活性。

Antimicrob Agents Chemother. 1989 Nov;33(11):1964-9. doi: 10.1128/AAC.33.11.1964.

9

Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.β-内酰胺酶抑制剂YTR 830、克拉维酸钠和舒巴坦与阿莫西林或氨苄西林联合使用的比较活性。

Antimicrob Agents Chemother. 1984 Oct;26(4):580-2. doi: 10.1128/AAC.26.4.580.

10

Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.

J Antimicrob Chemother. 1989 May;23(5):798-800. doi: 10.1093/jac/23.5.798.

引用本文的文献

1

Emergence of resistant isolates of Acinetobacter calcoaceticus- A. baumannii complex in a Spanish hospital over a five-year period.五年间西班牙一家医院中醋酸钙不动杆菌-鲍曼不动杆菌复合体耐药菌株的出现。

Eur J Clin Microbiol Infect Dis. 1996 Jun;15(6):512-5. doi: 10.1007/BF01691322.